Indicated as monotherapy for adults with HR-constructive, HER2-damaging Superior or metastatic breast cancer with disorder progression next endocrine therapy and prior chemotherapy in metastatic setting 200 mg PO BID A: Abemaciclib begins Functioning upon setting up the therapy, but obvious resul